Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2269557 in acute exacerbation of COPD
2014-001972-70Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing GSK2269557 + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Change from baseline in specific imaging Airways Volume (siVaw) at FRC and TLC. Started Nov 2014; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-001972-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001972-70.